Mike Simpson is the CEO of technology company Omura. Omura is a cannabis and CBD delivery platform, which combines heat-not-burn technology with pre-filled whole flower (called ‘Flowersticks’) for a modern, whole flower experience. More specifically, Omura uses whole flower sticks designed for use with the Omura heat-not-burn device to deliver a more hygienic and enjoyable experience for their customers, with a selection of brands and their preferred strains.
News and Updates
Do you or someone you know struggle with opioid use disorder? Chances are, at some point, you or someone you know has struggled with an addiction to opioids. One of the topics that we consistently discuss here at MyCureAll is the opioid epidemic. The CDC reports that over 67,000 people in the United States died in 2018 from opioids, an increase of 4% from 2017. With COVID-19 causing an increase in opioid use, these numbers will most likely continue to climb. However, while opioids are responsible for thousands of deaths every year, it is very unlikely to have a fatal overdose from cannabis. Sure, you may overdo it and have some symptoms which may even be severe, but you are unlikely to die from medical marijuana (as long as you don’t drive!)
Karen Berger, PharmD, Medical Writer COVID-19 is a pandemic that has brought a lot of devastation to the world. People are losing jobs, living in
Bryant registered his company, Roll Up Life, Inc., on November 6, 2019. When Bryant was growing up, one of his close friends was Precious Osagie-Erese. They played basketball together and were connected by their birthdays (Bryant’s is 9/9, and Osagie-Erese’s is 10/10). Not only that, but they were both at the top of the class in school and challenged each other intellectually. They reconnected a few years ago, and Osagie-Erese became chief marketing officer for Roll Up Life, Inc. She handles advertising and social media. “She is heaven sent to this operation,” Bryant says.
The MyCureAll family would like to acknowledge all of our fellow front-line workers helping the community during COVID-19 pandemic. As a group of pharmacists and social workers, we are engaged in providing healthcare to the community, too, and appreciate how difficult it is to balance work and family life, while we also have the fear of virus exposure despite taking appropriate precautions. Home schooling, dealing with isolation, and trying to find a balance with work (or for a lot of Americans, sudden unemployment) and personal life is a lot to juggle.
In the treatment of coronavirus (COVID-19), we have heard a lot about Gilead Science’s drug Remdesivir, which may be promising in shortening the duration of illness. We have heard about other antivirals, both previously developed and new ones in development. We have heard about plasma of recovered patients as an experimental treatment for COVID-19 patients. And of course, we have heard about vaccine trials. But until recently, we have not heard about medical cannabis or CBD for COVID-19.
April 20, or 4/20 (420), is known as “Weed Day.” What is the meaning behind this? There have been many rumors about the origin of 420, which include California criminal codes, police radio codes, and a very strange rumor about a Bob Dylan song. Chris Conrad, curator of the Oaksterdam Cannabis Museum in Oakland, California, set the record straight. Conrad explained that 420 was a secret code for high school students in the early 1970’s. A group of students at San Rafael High School in Marin County, California, called themselves “the Waldos,” and met at 4:20 p.m. every day after school to get high. These students, Steve Capper, Dave Reddix, Jeffrey Noel, Larry Schwartz, and Mark Gravich, called themselves the Waldos simply because they met at a wall, next to a statue of Louis Pasteur. This was the time that school was over, but their parents were not yet home, so the students met every day at that time to enjoy freedom and cannabis. The students started to say 420 as a code they could use in front of their parents, and the code spread across the state of California and then everywhere else.
A 2015 data review concluded that “existing preclinical evidence strongly supports the potential of CBD as a treatment for anxiety disorders,” and that “CBD exhibits a broad range of actions, relevant to multiple symptom domains, including anxiolytic, panicolytic, and anti compulsive actions, as well as a decrease in autonomic arousal, a decrease in conditioned fear expression, enhancement of fear extinction, reconsolidation blockade, and prevention of the long-term anxiogenic effects of stress.”